Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Postoperative adjuvant immunotherapy of gastric cancer with BCG-cell wall skeleton

3- to 6-year follow up of a randomized clinical trial

Summary

The clinical effectiveness of immunotherapy with the cell wall skeleton of Bacillus Calmette-Guérin was assessed in a study involving 140 consecutive patients with gastric cancer, who were gastrectomized at a single institution from January 1976 through December 1978. These patients were randomized by an envelope method after operation and divided into three treatment groups: ‘control’, ‘chemotherapy’, and ‘chemotherapy plus immunotherapy with BCG-CWS.’ Only two patients who died during surgery were excluded, and a survey of survival periods was made on the remaining 138 patients in January 1982.

As a result, statistically significant differences in the survival rate curve were observed between the control and chemotherapy plus immunotherapy groups (P<0.01), and between the chemotherapy and chemotherapy plus immunotherapy groups (P<0.05). These results emphasize effectiveness of BCG-CWS as an adjuvant immunotherapeutic agent in gastrectomized cancer patients.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Aungst CW, Sokal JE, Jager BV (1975) Complications of BCG vaccination in neoplastic disease. Ann Intern Med 82:666

  2. 2.

    Bast RC Jr, Zbar B, Borsos T, Rapp HJ (1974) BCG and cancer. (Part I of II) N Engl J Med 290:1413

  3. 3.

    Eilber FR, Morton DL, Holmes EC, Sparks FC, Ramming KP (1976) Adjuvant immunotherapy with BCG in treatment of regional lymph node metastases from malignant melanoma. N Engl J Med 294:237

  4. 4.

    Falk RE, MacGregor AB, Landi S, Ambus U, Langer B (1976) Immunostimulation with intraperitoneally administered Bacille Calmette Guérin for advanced malignant tumors of the gastrointestinal tract. Surg Gynecol Obstet 142:363

  5. 5.

    Gehan EA (1965) A generalized Wilcoxon test for comparing arbitrarily single-censored samples. Biometrika 52:203

  6. 6.

    Gutterman JU, Hersh EM, Rodriguez V, McCredie KB, Mavligit G, Reed R, Burgess MR, Smith T, Gehan E, Bodey Sr GP, Freireich EJ (1974) Chemoimmunotherapy of adult acute leukemia. Prolongation of remission in myeloblastic leukemia with BCG. Lancet II:1405

  7. 7.

    Japanese Research Society for Gastric Cancer (1981) The general rules for the gastric cancer study in surgery and pathology. Jpn J Surg 11:127

  8. 8.

    Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Statist Assoc 53:457

  9. 9.

    Mathé G, Amiel JL, Schwarzenberg L, Schneider M, Cattan A, Schlumberger JR, Hayat M, de Vassal F (1969) Active immunotherapy for acute lymphoblastic leukemia. Lancet I:697

  10. 10.

    Nakayama K (1968) Surgery of the stomach and duodenum. In: Atlas of gastrointestinal surgery. Igaku Shoin, Tokyo, p 235

  11. 11.

    Sparks FC, Ramming KP (1976) Immunotherapy of gastrointestinal cancer: The potential. Clin Gastroenterol 5:855

  12. 12.

    Stewart THM, Hollinshead AG, Harris JE, Belanger R, Crepeau A, Hoopoer GD, Sachs HJ, Klaassen DJ, Hirte W, Rapp E, Crook AF, Orizaga M, Sengar DPS, Raman S (1976) Immunochemotherapy of lung cancer. Ann NY Acad Sci 277:436

  13. 13.

    Yamamura Y, Sakatani M, Ogura T, Azuma I (1979) Adjuvant immunotherapy of lung cancer with BCG cell wall skeleton (BCG-CWS). Cancer 43:1314

  14. 14.

    Yasumoto K, Manabe H, Ueno M, Ohta M, Ueda H, Iida A, Nomoto K, Azuma I, Yamamura Y (1976) Immunotherapy of human lung cancer with BCG cell-wall skeleton. Gan 67:787

Download references

Author information

Correspondence to Takenori Ochiai.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Ochiai, T., Sato, H., Hayashi, R. et al. Postoperative adjuvant immunotherapy of gastric cancer with BCG-cell wall skeleton. Cancer Immunol Immunother 14, 167–171 (1983). https://doi.org/10.1007/BF00205355

Download citation

Keywords

  • Treatment Group
  • Cancer Patient
  • Cell Wall
  • Survival Rate
  • Gastric Cancer